tirzepatide vs semaglutide pancreatitis Semaglutide: 2026 Clinical Comparison Tirzepatide vs. Semaglutide for Weight

The starting dose is 1.5 mg, which can increase to a maintenance dose of 25 mg

The weight loss produced by GLP-1 medications is genuine and clinically significant trials of semaglutide (Wegovy) have shown average weight loss of 15 to 20% of body weight over 68 weeks, which is comparable to the outcomes of bariatric surgery for many patients

Patients who increase their dose gradually tend to experience milder and shorter-duration diarrhea compared to those who advance quickly

Supports faster recovery between training sessions, reduced injury risk, and enhanced tissue resilience under physical stress

EnGuide Pharmacy provides support from specially trained clinical pharmacists, flexible payment plans, and the convenience of having medications delivered safely and on time right to your doorstep

More than just a clinic, we are a supportive community dedicated to helping you achieve optimal health